A. McNicholl

发表

Response to: misleading results in the diagnosis of atrophic gastritis.

J. Gisbert, A. McNicholl, 2015, European journal of gastroenterology & hepatology.

Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement

J. Mate, J. Gisbert, F. Bermejo, 2009, Inflammatory bowel diseases.

Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.

F. Mégraud, J. Gisbert, F. Bazzoli, 2016, The Cochrane database of systematic reviews.

Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed

J. Gisbert, M. Chaparro, A. Marin, 2015, Alimentary pharmacology & therapeutics.

Research to the N-Power: The Strengths of Networked Clinical Collaboration in Spain

J. Gisbert, A. McNicholl, 2017, American Journal of Gastroenterology.

Thiopurine methyl‐transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine‐treated inflammatory bowel disease patients

F. Casellas, J. Mate, J. Gisbert, 2011, Alimentary pharmacology & therapeutics.

Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience

J. Mate, J. Gisbert, J. Mendoza, 2012, European journal of gastroenterology & hepatology.

Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection

J. Gisbert, M. Fernández-Bermejo, L. Rodrigo, 2014, Digestive Diseases and Sciences.

Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments

J. Gisbert, A. Federico, A. Lucendo, 2015, Alimentary pharmacology & therapeutics.

Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study

C. O'Morain, J. Gisbert, A. Lucendo, 2015, Alimentary pharmacology & therapeutics.

Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments.

J. Gisbert, A. Federico, A. Lucendo, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy

J. Gisbert, L. Rodrigo, J. Barrio, 2015, Digestive Diseases and Sciences.

Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies

J. Gisbert, A. McNicholl, 2017, Helicobacter.

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

J. Mate, J. Gisbert, C. Taxonera, 2009, Inflammatory bowel diseases.

Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis

J. Mate, J. Gisbert, F. Gomollón, 2009, Alimentary pharmacology & therapeutics.

Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease.

J. Gisbert, F. Gomollón, A. McNicholl, 2009, Inflammatory bowel diseases.

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.

J. Gisbert, J P Gisbert, A G McNicholl, 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

P119 - Efficacy of azathioprine and mercaptopurine in ulcerative colitis. Systematic review and meta-analysis

J. Mate, J. Gisbert, F. Gomollón, 2009 .

Heterogeneity of clinical management of low-grade gastric lymphoma of mucosa-associated lymphoid tissue. An audit of 198 patients in Spain

J. Gisbert, X. Calvet, D. Nicolás-Pérez, 2020, Gastroenterología y Hepatología (English Edition).

Heterogeneity of clinical management of low-grade gastric lymphoma of mucosa-associated lymphoid tissue. An audit of 198 patients in Spain.

J. Gisbert, X. Calvet, D. Nicolás-Pérez, 2019, Gastroenterologia y hepatologia.

Meta‐analysis: esomeprazole or rabeprazole vs. first‐generation pump inhibitors in the treatment of Helicobacter pylori infection

J. Gisbert, X. Calvet, O. Nyssen, 2012, Alimentary pharmacology & therapeutics.

Su1174 Sequential and Concomitant Treatments in H. pylori Eradication: A Network Meta-Analysis

J. Gisbert, O. Nyssen, A. McNicholl, 2014 .

Su1165 Meta-Analysis of Sequential vs. Standard Triple Therapy for Helicobacter pylori Eradication: Final Results of a Cochrane Systematic Review

F. Mégraud, J. Gisbert, F. Bazzoli, 2014 .

Su1171 Second-Line Rescue Triple Therapy With Levofloxacin After Failure of Non-Bismuth Quadruple “Sequential” or “Concomitant” Treatment to Eradicate H. pylori Infection

J. Gisbert, J. Barrio, J. Molina-Infante, 2014 .

Sa1265 Meta-Analysis on the Efficacy of a Second-Line Anti-TNF in Inflammatory Bowel Disease Patients With Failure to a Previous Anti-TNF Treatment

J. Gisbert, M. Chaparro, A. Marin, 2014 .

P411 Meta-analysis of the efficacy of a second-line anti-TNF in inflammatory bowel disease patients with failure to a previous anti-TNF treatment

J. Gisbert, M. Chaparro, A. Marin, 2014 .

Helicobacter pylori inactivation and virulence gene damage using a supported sensitiser for photodynamic therapy.

J. Gisbert, X. Calvet, D. García‐Fresnadillo, 2013, European journal of medicinal chemistry.

Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple “sequential” or “concomitant” treatment to eradicate H. pylori infection

J. Gisbert, J. Barrio, J. Molina-Infante, 2013, Scandinavian journal of gastroenterology.

Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice

J. Gisbert, X. Calvet, J. Barrio, 2013, Gut.

Sa1891 Helicobacter pylori Activates CD277, a New Co-Inhibitory Molecule

J. Gisbert, T. P. Cid, S. Benito-Martínez, 2013 .

Sa1882 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice

J. Gisbert, X. Calvet, Blanca Belloc, 2013 .

Sa1912 When Standard Triple Therapy With PPI+Amoxicillin+Clarithromycin Fails in the Eradication of Helicobacter pylori, What's Next?

J. Gisbert, A. Marin, A. McNicholl, 2013 .

Sa1884 Mutations in D-Loop Region of Mitochondrial DNA in Helicobacter pylori Infection

J. Gisbert, T. P. Cid, S. Benito-Martínez, 2013 .

Sa1917 Third-Line Rescue Therapy With Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (With Clarithromycin and Levofloxacin) to Eradicate Helicobacter pylori Infection

J. Gisbert, L. Rodrigo, J. Barrio, 2013 .

Commentary: comparators in H. pylori eradication — stating the ethics of statins

J. Gisbert, A. McNicholl, 2012, Alimentary pharmacology & therapeutics.

Su1689 Helicobacter pylori Infection in Spain: Is Its Prevalence Really Decreasing?

J. Gisbert, A. McNicholl, 2012 .

Su1708 Photodynamic Therapy: an Alternative Strategy Against Helicobacter pylori

J. Gisbert, D. García‐Fresnadillo, T. P. Cid, 2012 .

Su1685 Maintenance of Helicobacter pylori Eradication Rates With Triple Therapy Over 12 Years in a Spanish Hospital

J. Gisbert, A. McNicholl, 2012 .

Su1681 Meta-Analysis of Studies Comparing the First and New Generation Proton Pump Inhibitors in the Eradication of Helicobacter pylori

J. Gisbert, X. Calvet, O. Nyssen, 2012 .

OXIDATIVE STRESS CAUSED BY H. PYLORI DECIDES THE MITOCHON- DRIAL NETWORK FRAGMENTATION BY PROTEINS TRANSLOCATION (BAX AND DRP-1) TO FISSION SITES

M. Poljak, J. Gisbert, M. Homan, 2012 .

Su1694 Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori

J. Gisbert, A. Marin, A. McNicholl, 2011 .

Meta-Analysis: Rabeprazole and Esomeprazole in the Eradication of Helicobacter pylori

J. Gisbert, X. Calvet, O. Nyssen, 2011 .

Amoxicillin Gastric Retention Systems for Helicobacter pylori Treatment

J. Gisbert, S. Torrado, P. Torre, 2011 .

Usefulness of manometry to select patients with anal fissure for controlled anal dilatation.

J. Mate, J. Gisbert, R. Moreno-otero, 2010, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

M1698 Helicobacter pylori and Iron-Deficiency Anaemia (IDA): A Meta-Analysis of Case-Control Studies

J. Gisbert, O. Nyssen, A. McNicholl, 2010 .

M1697 Effect of Helicobacter pylori Eradication on Iron-Deficiency Anaemia (IDA): A Meta-Analysis of Randomized Clinical Trials

J. Gisbert, O. Nyssen, A. McNicholl, 2010 .

Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori

J. Gisbert, O. Nyssen, A. McNicholl, 2019, Helicobacter.

Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double‐blind, placebo‐controlled trial

J. Gisbert, J. Calleja, A. Lucendo, 2018, Helicobacter.

Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection.

J. Gisbert, Á. Lanas, X. Calvet, 2019, Gastroenterology & hepatology.

IV Spanish Consensus Conference on Helicobacter pylori infection treatment.

J. Gisbert, Á. Lanas, F. Mearin, 2016 .

Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.

J. Gisbert, A. McNicholl, M. G. Donday, 2017, Gastroenterologia y hepatologia.

Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2019, Helicobacter.

Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions

J. Gisbert, M. Ricote, X. Calvet, 2019, Helicobacter.

A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)

J. Gisbert, A. Marin, A. McNicholl, 2013, Expert opinion on pharmacotherapy.

[European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years].

O. V. Zaitsev, E. A. Ageeva, F. Mégraud, 2019, Terapevticheskii arkhiv.

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.

F. Mégraud, C. O'Morain, J. Gisbert, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers].

C. O'Morain, J. Gisbert, N. Zakharova, 2016, Terapevticheskii arkhiv.

Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection

J. Gisbert, Á. Lanas, X. Calvet, 2020, Gastroenterología y Hepatología (English Edition).

Empirical Helicobacter pylori rescue therapy: an 18‐year single‐centre study of 1200 patients

J. Gisbert, D. Burgos-Santamaría, A. McNicholl, 2019, GastroHep.

Helicobacter Pylori Treatment Results in Slovenia in the Period 2013-2015 as a Part of European Registry on Helicobacter Pylori Management

F. Mégraud, C. O'Morain, J. Gisbert, 2017, Radiology and oncology.

European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in Russia.

O. V. Zaitsev, E. A. Ageeva, F. Mégraud, 2018, Terapevticheskii arkhiv.

Optimum second-line regimens for Helicobacter pylori eradication

J. Gisbert, Yuhong Yuan, G. Leontiadis, 2014 .